Day: June 29, 2020

Press ReleaseNokia wins exclusive Taiwan Mobile 5G dealNokia selected as single vendor for 5G RAN, Core and IMS in three-year deal  Continues long-standing partnership into 5G eraTaiwan Mobile pursuing 5G strategy focused on digital transformation and sustainability29 June 2020Espoo, Finland – Nokia today announced that it has been selected by Taiwan Mobile (TWM) as the sole supplier of its 5G network in a three-year framework deal worth approximately 400 million euros. The initial phase of the deal, which includes 5G RAN, 5G Core and 5G IMS, begins this month with the deployment of 5G non-standalone with the aim of migrating to 5G standalone within a three-year period. Nokia is a long-standing partner of TWM and will support the company in its efforts to execute its ‘Super 5G strategy’ which is focused on sustainability and digital transformation....

Stockholm, Sweden, June 29, 2020 – Hoylu, a leader in visual collaboration solutions for distributed teams, has today released an integrated Module for PI (Program Increment) Planning. PI Planning sessions are regularly scheduled team events for large software development programs where all the smaller agile teams come together to create alignment, exploit synergies and to agree a plan for the next planning period. PI Planning sessions are the biggest and most important events in the Scaled Agile Framework (SAFe), a methodology which aims to help larger organizations manage projects when more than one team is working on a product.Hoylu’s PI Planning Module is another value enhancing component of its Connected Workspaces™ online digital whiteboard platform that transform the workspace using rules and functions that precisely fit the workflow...

Stockholm, Sverige, den 29 juni 2020 – Hoylu, ledande inom visuella samarbetslösningar för distribuerade team, har idag släppt en integrerad modul för PI (Program Increment) Planning. PI Planning sessioner regelbundet planeras teamevenemang för stora program inom mjukvaruutveckling, där alla mindre agila team samlas för att skapa anpassning, utnyttja synergier och komma överens om en plan för nästa planeringsperiod. PI Planning sessioner är de största och viktigaste händelserna i Scaled Agile Framework (SAFe), en metod som syftar till att hjälpa större organisationer att hantera projekt när mer än ett team arbetar med en produkt.Om HoyluHoylu s uppdrag är att göra distansarbete och informationsutbyte lätt. Genom våra anpassningsbara Connected Workspaces™ levererar vi programvarulösningar för företag, organisationer och individer i praktiskt...

Lufthansa becomes first globally leading airline with a solution for safe and convenient international air travel during this pandemicLandmark exclusive cooperation offers testing for passengers departing from or arriving at Frankfurt airport starting immediatelyInnovative concept supports a safe reopening of air travel and further steps towards a new normal for our societies and economiesCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 29, 2020 (GLOBE NEWSWIRE) — CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced today that it has partnered exclusively with Lufthansa and with Fraport, the operator of Frankfurt Airport, to offer COVID-19 testing to passengers...

HERZLIYA, Israel, June 29, 2020 (GLOBE NEWSWIRE) — Safe-T® Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions for on-premise and hybrid cloud environments, today announced that it has launched a unique implementation of its Zero-Trust Secure File Access (SFA) Solution as Server Message Block (SMB) Proxy for Windows File Sharing. The unique solution was selected by a leading intelligence unit, after successfully winning a tender process. The purchase order, in a gross amount of approximately US$225,000, is for a perpetual license, with a one-year maintenance period.Shachar Daniel, Safe-T Group’s CEO, commented: “We are proud to be the first to introduce our Zero-Trust SFA solution as SMB proxy and to have been selected over other file access vendors to provide our solution to a leading intelligence unit specializing...

Hørsholm, Denmark (29 June 2020) – Oncology Venture A/S (“OV” or the “Company”) today announced that it has signed a definitive agreement out-licensing two clinical pipeline assets, LiPlaCis® and 2X-111, to Smerud Medical Research International for further clinical and commercial development. Under the terms of the agreement, OV will receive regulatory milestone fees of nearly US $30M plus royalties on sales for each drug payable to OV if all the milestones are met. OV also terminated its prior license agreement with Cadila Pharmaceuticals for the development of LiPlaCis® in India.In September 2019, OV announced a significant restructuring, including a new executive management team and a streamlined, prioritized focus on advancing its top three clinical-stage oncology programs towards approval and commercialization.  The Company has worked...

ST HELIER, Jersey, June 29, 2020 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or the “Company”) (NYSE AMERICAN: CMCL; AIM: CMCL) today announces that the Board of Directors has declared a further increased quarterly dividend of eight and a half United States cents (US$0.085) on each of the Company’s common shares.Highlights13 per cent increase from the previous quarterly dividend of 7.5 cents, which, together with the increase to the dividend in January 2020 from 6.875 cents, represents a cumulative 24% increase since October 2019.Significant business resilience demonstrated through the COVID 19 pandemic with gold production levels still within the range of 2020 guidance of 53,000 – 56,000 ouncesStable production, a high gold price and good cost control have resulted in increased cash generation in 2020;...

AIM & TSX: “TGL” & NASDAQ: “TGA”This Announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 (“MAR”). Upon the publication of this Announcement, this inside information is now considered to be in the public domain.CALGARY, Alberta, June 29, 2020 (GLOBE NEWSWIRE) — TransGlobe Energy Corporation (“TransGlobe” or the “Company”) announces an operations update. All dollar values are expressed in US dollars unless otherwise stated.UPDATESProduction has averaged 14,447 Boepd in Q2 2020 to date (April 14,378 Boepd, May 14,334 Boepd and June 1 to June 19 14,740 Boepd) versus 14,997 Boepd in Q1 2020;Production guidance for 2020 remains unchanged at an average of 13,300 to 14,300 Boepd;Sold ~100,000 bbls oil in each of the months of April and May to EGPC, with net proceeds of ~$4.0...

Geneva, Switzerland and Boston, MA – June 29, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that it will release Phase 3 results from the  PRIMROSE 1 and PRIMROSE 2 clinical trials of linzagolix for the treatment of heavy menstrual bleeding due to uterine fibroids, on Monday July 6, 2020. ObsEva management will host an investment community conference call at 8 a.m. Eastern Time, 2 p.m. Central European Time, Monday July 6, 2020  to discuss these results. Investors may participate by dialing (844) 419-1772 for U.S. callers or +1 (213) 660-0921 for international callers, and referring to conference ID 6673575.  A webcast of the conference call can be accessed via the Events Calendar under the “Investors”...

Die Analyse der Behandlungsergebnisse bei fünf schwer erkrankten COVID-19-Patienten ergab erhebliche Vorteile für Patienten, die im Rahmen eines Härtefallprogramms mit Opaganib behandelt wurden, sowohl bei den klinischen Ergebnissen als auch bei den Entzündungsmarkern im Vergleich zu einer gematchten Fall-Kontroll-Gruppe im selben Krankenhaus—Alle Patienten in der mit Opaganib behandelten Gruppe wurden ohne mechanische Beatmung aus dem Krankenhaus entlassen, während 33 % der gematchten Fall-Kontroll-Gruppe eine mechanische Beatmung benötigten—Die mittlere Zeit bis zur Entwöhnung von der Nasenkanüle mit hohem Durchfluss wurde in der mit Opaganib behandelten Gruppe auf 10 Tage verkürzt, im Vergleich zu 15 Tagen in der gematchten Fall-Kontroll-Gruppe—Es wurden Anträge für eine randomisierte, doppelblinde, placebokontrollierte...